Indication
Rhabdoid Tumor of the Kidney
3 clinical trials
4 products
2 drugs
Clinical trial
Phase 2 Proof of Concept Study of Nivolumab and Ipilimumab in Children and Young Adults With Relapsed or Refractory INI1-negative CancersStatus: Recruiting, Estimated PCD: 2024-10-01
Product
NivolumabProduct
IpilimumabClinical trial
Treatment for Patients With Bilateral, Multicentric, or Bilaterally-Predisposed Unilateral Wilms TumorStatus: , Estimated PCD: 2016-12-31
Product
DactinomycinDrug
R-CHOPDrug
VincristineClinical trial
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Tipifarnib in Patients With Tumors Harboring HRAS Genomic AlterationsStatus: Active (not recruiting), Estimated PCD: 2024-03-31
Product
Tipifarnib